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Relative quantitation of aspartyl and isoaspartyl residue mixtures from asparagine deamida-
tion is demonstrated using electron capture dissociation without prior HPLC separation. The
method utilizes the linear relationship found between the relative abundance of the isoaspartyl
diagnostic ion, zn-57, and % isoaspartyl content based on the ECD spectra of known
isoaspartyl/aspartyl mixtures of synthetic peptides. The observed linearity appears to be
sequence independent because the relationship exists despite sequence variations and changes
in backbone fragment abundances when isoaspartyl and aspartyl residues are interchanged.
Furthermore, a new method to calculate the relative abundances of isomer from protein
deamidation without synthetic peptides is proposed and tested using a linear peptide released
by protein digestion that contains the deamidation site. The proteolytic peptide can be rapidly
aged to the expected 3:1 (isoaspartyl:aspartyl) mixture to generate a two-point calibration
standard for ECD analysis. The procedure can then be used to determine the relative
abundance of deamidation products from in vivo or in vitro protein aging
experiments. (J Am Soc Mass Spectrom 2007, 18, 48–56) © 2007 American Society for Mass
SpectrometryInpeptides and proteins, deamidation of asparaginyland isomerization of aspartyl (Asp) residues canoccur spontaneously to form a mixture of isoaspar-
tyl (isoAsp) and Asp residues (Figure 1) [1–3], a process
believed to be a common in vivo degenerative pathway
for proteins that affects their structure [4 – 6] and activ-
ity [7–9]. The rate of deamidation is influenced by steric
effects from the C-terminal amino acid neighbor [10] to
asparagine and local three-dimensional structure [11].
For example, under physiological conditions, linear
peptides with -NI- were shown to have a deamidation
half-life of 300 d opposed to peptides with -NG- that
had a half-life of 1 d [10]. Therefore, deamidation of
-NG- is a common peptide modification that results
from in-gel digestion protocols that require overnight
incubation in ammonium bicarbonate (pH 8.5) with
trypsin [12, 13]. Asp isomerization is also possible
(Figure 1), but occurs 40 times slower than deamida-
tion [2] and is therefore a less prevalent modification.
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doi:10.1016/j.jasms.2006.08.008The isoAsp form has the -carbon originally of the side
chain inserted into the backbone altering the fundamen-
tal protein structure and is believed to contribute to
disruption of protein structure and function more than
the Asp form [14]. Hydrolysis of the succinimide inter-
mediate in linear peptides typically results in an ap-
proximate 3:1 ratio of products favoring the isoAsp
form [15–21], but ratios from succinimide hydrolysis
within a structurally restricted environment, such as
within a protein’s tertiary structure, can deviate from
this ratio [22]. For example, N67 of ribonuclease A
ultimately deamidated to a 3:2 ratio in favor of the Asp
form due to the restricted flexibility of the region by two
flanking disulfide bonds [23]. Therefore, a method that
determines the relative abundance of the products is
necessary for complete characterization of asparaginyl
deamidation and Asp isomerization that is suspected to
affect a protein’s structure and function.
Analytical techniques spearheading the analysis of
asparaginyl deamidation include radiolabeling, isoelec-
tric focusing (IEF) gel electrophoresis and ion-exchange
high-performance liquid chromatography (HPLC), re-
verse phase HPLC, Edman degradation, and mass
spectrometry (MS). Radioactive methods utilize the
enzyme protein isoaspartyl methyl transferase (PIMT)
to selectively methylate isoAsp residues in peptides and
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detecting deamidation, but not localizing the site or
determining the relative abundance of the products [24,
25]. Separation of proteins from their deamidated coun-
terparts can be done by ion-exchange HPLC [23, 26, 27]
or IEF gel electrophoresis [14, 28] because there is a net
change in the isoelectric point with deamidation. How-
ever, the methods are not used for differentiation and
relative quantitation of the deamidation products be-
cause the acidity constants of the isomers are so similar;
isoAsp and Asp were shown to have a difference of
only 0.7 pKa units [17]. Deamidated proteins are often
digested to localize the deamidation site and determine
the ratio of products by reverse-phase HPLC [19, 20,
26], but separation of the isomers can be challenging.
Several difficulties are encountered when separating
Asp/isoAsp peptides by reverse-phase HPLC; custom-
ized separation for each peptide mixture, increased
analysis time and sample consumption, and interfer-
ence from other peptides. The slight structural differ-
ences between isoAsp and Asp residues in peptides can
make their separation challenging, so shallow gradients
and long run times are often necessary for baseline
separation. For example, a gradient of 15–19% organic
mobile phase in 60 min was required to achieve baseline
separation of isoAsp/Asp peptides from a tryptic digest
[20]. Furthermore, larger peptides reduce the influence
of the structural difference (isoAsp versus Asp) that is
critical for separation and may render these mixtures
inseparable. Many HPLC runs are often required before
Figure 1. The standard model for deamidation of asparaginyl or
isomerization of Asp residues to a mixture of Asp and isoAsp
residues.adequate separation is achieved, thus increasing totalanalysis time and sample consumption. Finally, isomers
existing in a complex mixture, such as a protein digest,
may have retention times similar to other species mak-
ing their relative quantitation more problematic.
Once separation is completed, Edman degradation
or MS can differentiate the isomers. Edman degrada-
tion, which is blocked by isoAsp residues [29], requires
both chemical and HPLC procedures for sequence de-
termination, thus lengthening analysis time. Substitut-
ing Edman degradation for MS can shorten analysis
time but differentiation is difficult because there is no
mass difference between the isomers. Differences in the
fragment mass spectra of the isomers are therefore
required for differentiation.
Collisionally activated dissociation (CAD) [30, 31] in
MS can differentiate Asp from isoAsp residues using
fragmentation patterns particular to each form but
peptide standards are necessary because the method
relies on the relative intensity of fragments for differ-
entiation [32–35]. Electron capture dissociation (ECD)
[36] in a Fourier transform mass spectrometer (FTMS)
[20, 37] or electron-transfer dissociation (ETD) [38] in an
ion trap can differentiate the two forms using a diag-
nostic ion unique to the isoAsp form without the need
for peptide standards.
ECD is a sequencing tool that involves the reaction of
electrons with gas-phase multiply charged peptide and
protein cations. The captured electron initiates N-C
bond cleavage producing c and z· type fragment ions
(N- and C-terminal fragments, respectively) and can
preserve posttranslational modifications linked to the
fragments [39, 40]. ECD can also cleave bonds in amino
acid side chains such as the C-C bond [41]. For Asp
residues, this results in M·-60, but for isoAsp residues,
cleavage of the C-C backbone bond by ECD generates
cln57 and zn-57 (n is isoAsp, l is length of the peptide)
fragment ions thus detecting and localizing the isoAsp
residue. Analysis of deamidated peptides from proteins
with HPLC and ECD [20] demonstrated that the com-
bined technique easily differentiates and determines the
relative abundance of products but the method is still
subject to the limitations associated with HPLC method
development described above.
Relative quantitation of isomers with MS alone using
fragmentation patterns unique to each form determined
the relative abundances of sulfated disaccharides re-
leased from digestion of chondroitin [42, 43], suggesting
that an analogous method could be developed for
relative isoAsp/Asp quantitation. The possible sulfate
positions in disaccharides from chondroitin are few
compared with the possible amino acid sequences ob-
tained from proteins so a fragmentation trend repro-
ducible for all peptides from proteins is ideal. In this
study, ECD spectra of three shynthetic peptides mixed
at different percent isoAsp/Asp compositions showed a
reproducible correlation between the relative abun-
dance of the isoAsp diagnostic ion and mixture compo-
sition. A method is then suggested using this relation-
ship for complete characterization of asparagine
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chrome c as a model.
Experimental
Materials
Rink resin (1.2 mmol/g loading), HBTU [O-(benzo-
triazol-1-yl)-N,N,N N=-tetramethyluronium hexaflu-
orophosphate] and the FMOC [N--(9-fluorenylme-
thoxycarbonyl)]-protected amino acids glutamic acid,
glutamine, isoleucine, histidine, tyrosine, and threo-
nine were purchased from Advanced Chemtech (Lou-
isville, KY). FMOC-protected isoAsp was purchased
from NovaBiochem (La Jolla, CA). Trypsin was pur-
chased from Roche chemicals (Indianapolis, IN). All
other chemicals were purchased from Sigma Aldrich
(St. Louis, MO).
Peptide Synthesis
Peptides were synthesized by a standard manual solid-
phase peptide synthetic method in 1 mL polypropylene
syringe barrels (Supelco, St. Louis, MO) utilizing a
polyethylene frit (0.2 mL). For each step, 500 uL of the
appropriate wash or reaction solution was added to the
tube, sealed on both ends with stoppers, mixed on a
rotisserie shaker for the specified amount of time, and
the remaining solution was removed by vacuum filtra-
tion (the terms “(X  Y min)” means mixing for Y min
followed by filtration, done X times). In a typical
reaction sequence: resin was pretreated with DMF
(N,N-dimethylformamide) (3  1 min); treated with
20% piperidine solution in DMF (1 1 min, 1 20 min)
to remove the FMOC protecting group; washed to
provide the free amine [DMF (3  1 min), DCM
(dichloromethane) (3  1 min), ethanol (3  1 min),
DCM (3  1 min), and DMF (3  1 min)]; reacted with
a 600 mL mixture of the appropriate amino acid solu-
tion (two equivalents of FMOC-amino acid, HBTU and
DIPEA (N-ethyldiisopropylethanolamine) in DMF pre-
activated by mixing for 5–8 min) for 2 h; washed to
remove residual reactants [DMF (3  1 min), DCM (3 
1 min)]; dried and stored under vacuum or the cycle
was repeated for the next amino acid. About two
residues per day were added making total synthesis
time 3 weeks for three sets of unpurified peptides.
When peptide synthesis was complete, pretreatment
with DMF, deprotection and washing with ethanol was
completed and the resin was dried under vacuum
overnight. Cleavage of the peptide from the resin was
done using a 1 mL solution of TFA (trifluoroacetic
acid):DCM:TIPS (triisopropylsilane):water (45:45:5:5)
with mixing for 2 h under nitrogen followed by precip-
itation in cold ether. All peptides were purified using
reverse phase HPLC with single wavelength detection
at 278 nm using a mobile phase system of 5% acetoni-
trile in water with 0.05% TFA (mobile phase A) and
100% acetonitrile with 0.035% TFA (mobile phase B).YWQHTA(isoD/D)QFR-NH2 was purified by a gra-
dient of 7–15% B in 30 min on a 4.6 mm i.d.  250 mm
C18 column (Vydac, Hesperia, CA) at 0.5 mL/min
using a System Gold 125 pump and 166 detector (Beck-
man Coulter, Fullerton, CA). Y(isoD/D)FIEYVR-NH2
and WAF(isoD/D)SAVAWR-NH2 were purified using
gradients of 15–20% B in 23 min and 15–25% in 50 min,
respectively, on a 10 mm i.d.  250 mm C18 column
(Vydac, Hesperia, CA) at 4 mL/min using Waters 510
HPLC pumps with gradient controller and model 490
wavelength detector (Millipore, Billerica, MA). Peptide
sequences were confirmed by FTMS-ECD analysis.
Stock solutions ranging from 0–100% isoAsp (10%
increments) for each set of isomeric peptides were
prepared and diluted for FTMS-ECD analysis.
Protein Digestion and Aging
Cytochrome c was digested with trypsin (100:1, wt/wt)
in 0.1 M ammonium bicarbonate for 5 h at 37 °C. The
digest was dried to remove the buffer, 5% ammonium
hydroxide (pH 12) was added, and the peptide solution
was incubated overnight at 80 °C to completely de-
amidate N31 of 28TGPNLHGLFGR
38 to the isoAsp/
Asp mixture. The solution was dried under vacuum
centrifugation to remove ammonia and then analyzed
by FTMS-ECD as described below. The peptide
28TGPDLHGLFGR
38 and its isoAsp counterpart from
cytochrome c used as calibration samples were pre-
viously separated [20].
Mass Spectrometry
ECD experiments were performed on a custom-built
FTMS instrument previously described [44, 45]. Peptide
solutions were prepared at 105 M from stock solu-
tions in a 49.5:49.5:1 water:methanol:formic acid solu-
tion and 5 L was loaded into a glass capillary with 1
m orifice made using mechanical tip puller (Sutter
Instruments, Novato, CA). Applying 1.2 kV to the
solution generated positively charged ions used for
FTMS-ECD analysis. For each experiment, the (M 
2H)2 species was isolated by Q1, accumulated in Q2
for 100–1000 ms, transferred to the ICR cell by gated
trapping, and then irradiated with electrons at 0.25 eV
for 50–200 ms. ECD fragments were detected using a
typical excitation/detection sequence with 20 scan sig-
nal averaging. Accumulation times for (M  2H)2
were optimized to achieve a signal/noise ratio of 500.
All analyses were performed in triplicate to generate
some understanding of abundance variance upon ECD.
Results and Discussion
ECD of all isoAsp peptides generated the zn-57 diag-
nostic fragment ion that was not found in correspond-
ing Asp ECD spectra (e.g., YWQHTADQFR-NH2, Fig-
ure 2a). All mixtures showed increasing zn-57
abundance with increasing isoAsp content. For exam-
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YWQHTADQFR-NH2 at different Asp/isoAsp ratios,
clearly demonstrating the changes in relative abun-
dance of this ion. Relative abundance of the zn-57
fragment (Rel[zn-57]) with respect to all backbone frag-
ments found in the spectra (y, z, c, and their neutral
losses) was calculated and plotted against % isoAsp
content for all peptide mixtures (Figure 3). All plots
exhibited a near linear relationship with R2 values
greater than 0.98 but with different slopes.
For all three peptide mixtures, particular backbone
fragment ion abundances change when the Asp or
isoAsp residues are interchanged. The increasing or
decreasing fraction of gas-phase structures belonging to
one form versus another may account for these trends
since intramolecular hydrogen bonding has been
shown to remain after ECD cleavage [46, 47]. For the
peptide WAFDSAVAWR-NH2, no fragments that ac-
count for at least 5% of the total fragment abundance
(excluding cleavage on either side of isoAsp/Asp)
change more than 50%, suggesting only a minor change
Figure 2. (a) ECD fragment spectra of YWQHT
daggers represent ions from incomplete isolation
ics. (b) The 400–560 m/z region from the ECD
mixtures [boxed region from (a)].ADQFR-NH2 and YWQHTAisoDQFR-NH2. Double
and asterisks represent electronic noise or harmon-
fragment spectra of YWQHTA(D/isoD)QFR-NHin gas-phase structure with isoAsp substitution. How-Figure 3. Plots of the zn-57 relative abundance versus % isoAsp
content for; [filled triangle], YWQHTADQFR-NH [filled dia-2;
mond], WAFDSAVAWR-NH2; [filled square], YDFIEYVR-NH2.
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and YDFIEYVR-NH2 show 60 and 33% of the fragment
abundances experience a 50% change or more with
isoAsp substitution. This is probably due to the glu-
tamic acid in Y(isoD/D)FIEYVR-NH2 and two glu-
tamines and histidine residues in YWQHTA(isoD/
D)QFR-NH2. Hydrogen bonding involving these
residues may be hindered or favored when interchang-
ing Asp and isoAsp residues. Therefore, determining %
isoAsp content using the relative intensities of zn-57 and
any other particular backbone fragment that unknow-
ingly varies may generate erroneous results. Despite the
fluctuations in ion abundances, the data demonstrates
the trend found between Rel[zn-57] and % isoAsp
content is linear indicating that total fragment ion
abundance remains fairly constant even if particular
ions show substantial abundance variation. Further-
more, the linearity of these plots appears to be sequence
independent but that relationship itself (the slope) is
peptide dependent. Similar trends may be observed for
CAD spectra since fragments resulting from cleavages
adjacent to Asp residues change in abundance upon
isoAsp substitution [32–35]. However, detection alone
by CAD relies on discerning the relative intensities of
fragments whose formation are collision energy depen-
dent, so careful control over experimental parameters
are probably necessary to generate useful calibration
curves. The isoAsp diagnostic ion from ECD spectra
offers unambiguous detection and calibration plots that
Figure 4. Scheme for generating a two-point ca
digest.pass through the origin offering a more straightforwardprocedure over CAD. Despite the advantage of using
ECD, relative quantitation of asparaginyl deamidation
or Asp isomerization products by either technique
requires synthetic peptides for generating calibration
curves.
Since random coil peptides typically produce a 3:1
ratio of isoAsp:Asp upon asparagine deamidation, the
enzymatic digest peptide from the protein itself can
potentially be used to generate a standard for quantita-
tion. Clarke [15], Aswad [16], Capasso [17] and others
[18 –20] have shown asparagine deamidation in linear
peptides to produce mixtures ranging from 70 to 80% in
favor of the isoAsp form. Considering these data, rapid
aging of a peptide with an asparaginyl residue released
from a protein by enzyme digestion should produce the
75% isoAsp mixture that can be used for calibration. A
two point calibration line generated connecting the
Rel[zn-57] (75% point) from the peptide ECD spectrum
and the point of origin can then be used to quantify the
relative abundance of products from the in vivo or in
vitro deamidation of the protein (Figure 4).
Cytochrome c was chosen to test this method in a
real protein. The tryptic peptide, 28TGPNLHGLFGR
38
was previously deamidated and its isoforms were sep-
arated by HPLC [20]. A two-point calibration equation
therefore already exists (y  0.0259x) using the ECD
spectra of the 100% Asp and 100% isoAsp peptide, and
was used to test whether a 75% isoAsp mixture is
generated by this method (Figure 5). A 5-h trypsin
tion from a deamidated peptide from a proteinlibradigestion of cytochrome c produced the peptide
8iously
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38 (m/z  584.815, 2) that was to be
deamidated. Leucine on the C-terminal side of aspara-
gine is believed to sterically hinder deamidation (1/2
life  128 days at pH 7.4 and 37 °C) [10] so harsh aging
conditions were used to deamidate the peptide. FTMS
analysis of the tryptic digest after a 16 h incubation at
pH 12 and 80 °C showed complete deamidation indi-
cated by a 0.984 Da shift in its isotopic pattern (m/z 
585.307, 2). The ECD spectrum of the peptide con-
firmed the sequence was a mixture as revealed by
presence of the z8-57 fragment ion and a peak corre-
sponding to the loss of an Asp side-chain ([M 
2H]·-60Da) [37]. A value of 0.0191  0.0007 for the
Rel[z8-57] calculated from the ECD spectra corresponds
to 74%  4% isoAsp content which falls near the
expected 75% value (Figure 5). This supports the hy-
pothesis from the procedure presented that a two-point
calibration based on the 75% point (% unknown isoD
 Rel[isoD(unknown)]/Rel[isoD(75% point)]  75%)
can be used to determine the relative abundance of
deamidation products from a protein without the need
for synthetic peptides.
Determining the relative abundance of isoAsp resi-
Figure 5. Rel[z8-57] from the ECD spectra of de
using the plot of % isoAsp content versus Rel[z
TGPDLHGLFGR and TGPisoDLHGLFGR, prevdues resulting from Asp isomerization using the proce-dure may be possible, but there is no mass change with
isomerization, and the point at which the ratio remains
constant represents complete Asp isomerization. Pep-
tides containing the DG sequence were shown to pro-
duce a 3:1 (isoAsp:Asp) ratio at equilibrium when
incubated in a basic environment (pH 7) [17], suggest-
ing that the method described above could be applied
to Asp isomerization. However, the rate of Asp isomer-
ization is about 40 times slower than deamidation [2], so
longer and harsher conditions than those typically used
for deamidation may be required to force complete
isomerization, and such conditions may affect the 3:1
predicted ratio. For example, direct hydrolysis of the
side chain amide group to a carboxyl group is promoted
when succinimide formation is hindered ([1], p.32). This
situation would shift the ratio of products away from
the expected 3:1 ratio and even more so if the C-
terminal neighbor to Asp is a bulky residue. Therefore,
additional data may be necessary to confidently say the
method proposed above is applicable to Asp isomeriza-
tion and synthetic standards may be necessary for
quantitating the ratio.
All peptides for this study were synthesized with
ated TGPNLHGLFGR corresponds to 74% 4%
constructed from the ECD fragment spectra of
separated.amid
-57]C-terminal arginines to simulate tryptic peptides, and
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nonpolar residues and position of the isoAsp residue
to better represent the sequence diversity found in
proteins. The reproducibility of the linear relation-
ship among the four peptides shown strengthens the
claim that this method is a useful tool for relative
isoAsp/Asp quantitation from asparagine deamida-
tion but only when trypsin is used for protein diges-
tion. The sequence diversity of peptides generated
using other enzymes (e.g., Glu-C, Lys-C) should
statistically be similar to trypsin although their size
may be larger. This suggests the applicability of using
the isoaspartyl quantitation method to those employ-
ing an enzyme other than trypsin, although addi-
tional experiments should be conducted to test this
claim.
The procedure for isoaspartyl quantitation by ECD
assumes that a peptide, when harshly deamidated with
high temperature, will always achieve a 3:1 ratio. While
this assumption is clearly true in the case studied here,
it may not be true for all peptides. For example, the
competing pathway of direct hydrolysis could alter the
ratio when C-terminal neighbors to asparagine are
those that greatly reduce the rate of deamidation (e.g.,
valine, isoleucine) ([1], p. 32). Also, Asp and isoAsp
could reform the succinimide intermediate when longer
incubation periods are required for complete deamida-
tion. Therefore, in cases where more accurate numbers
are needed, full calibration plots will have to be gener-
ated using pure isoAsp and Asp peptides either from
HPLC fractionation, as shown with cytochrome c, or
synthetically produced, peptides as shown above. Nev-
ertheless, the 3:1 mol ratio from the method presented
does generate a good starting point and accurate rela-
tive estimates.
Finally, to successfully quantitate isoaspartyl resi-
dues, a suitable peptide must be obtained that contains
the deamidation site and that generates an ECD spec-
trum with the isoaspartyl diagnostic ion. Some practical
obstacles therefore may be encountered when employ-
ing the method such as procuring enough protein for
the procedure, isolating a peptide with the deamidation
site in the mass spectrometer, and generating a useful
ECD spectrum from that peptide for quantitation. First,
the low-level amount of proteins typically obtained
from biological samples is a practical limit to this and
most quantitation methods and may prohibit the use of
the method entirely or require extensive chromato-
graphic cleanup procedures. Other methods may be
necessary, such as immunological [48] or radioactive
[25] methods, but these methods can only detect isoas-
partyl residues, and cannot localize or quantitate the
relative abundance of deamidation products. Second, as
proteins become larger, their digestion mixtures be-
come more complex. This may result in overlapping
species in the broadband ESI spectrum, making isola-
tion of the peptide of interest difficult or impossible.
Fractionation of the digest therefore may be necessary
to reduce the complexity of the mixture, but not asrigorous a separation as one required to differentiate
isoAsp- from Asp-containing peptides. Furthermore,
the peptides used in the experiments were relatively
small (1500 Da) and the ECD spectrum of the 2
charge state for each peptide fortunately showed all
interresidue cleavages including the isoaspartyl diag-
nostic ion. Therefore, it is important to use a peptide
that is favorable for ECD analysis. There are several
factors that affect the ECD process, such as the increase
in capture cross-section with charge [49], the hydrogen
bonding between fragments that remain after the ECD
event [46, 47], and the distance between the charges and
cleavage sites [50]. Because of these factors, a multiply
protonated peptide whose charges are uniformly dis-
tributed is preferred to facilitate a complete cleavage
pattern and ensure detection of a possible isoaspartyl
residue, but it is not always necessary. For example,
ECD of the 3 charge state of a 2850 Da tryptic
fragment from ribonuclease A showed the diagnostic
isoaspartyl fragment ion but failed to produce frag-
ments representing all interresidue cleavages [20]. De-
spite all the possible hurdles discussed, the procedure
presented should provide a convenient, MS-based
method for relative isoaspartyl quantitation although
additional steps may be necessary to obtain the neces-
sary peptide and generate an adequate ECD spectrum
for calculating Rel[zn-57].
Conclusions
The plots of Rel[zn-57] versus % isoAsp content for
three sets of synthetic peptides suggest that the linear
relationship found is peptide independent but that
the slopes are sequence-dependent, and synthetic
standards of each form (isoAsp and Asp) are required
for generating calibration curves. However, a method
is suggested for determining the relative amounts of
protein deamidation products from in vivo or in vitro
experiments without the need to synthetic standards.
The procedure involves rapid and harsh aging of the
proteolytic peptide containing the deamidation site
that can be used to generate a standard mixture for
calibration, assuming that the often observed 3:1
(isoAsp:Asp) molar ratio holds true for the peptide of
interest, for determining the relative amounts of
protein deamidation products. This assumption was
tested for cytochrome c and appears to be valid.
Two important attributes of using ECD to quantitate
the relative abundance of isoAsp residues are the elim-
ination of both the need for HPLC separation and the
necessity of peptide standards for relative quantitation.
Elimination of the HPLC step is beneficial because it
dramatically shortens experiment time and decreases
sample consumption. This is important considering the
amount of protein obtained from typical proteomic
experiments. Peptide synthesizers remove tedious man-
ual peptide synthesis but steps such as cleanup proce-
dures and peptide characterization are still required, so
55J Am Soc Mass Spectrom 2007, 18, 48–56 QUANTITATIVE ABUNDANCE OF ISOASPARTYLobtaining the standard directly from the protein is not
only facile but also economical.
In conclusion, the method presented should be a
practical approach for studies involving proteins that
have been determined to deamidate but for which the
relative abundances of their Asp and isoAsp products
are still unknown.
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